Painkillers in higher doses, taken over longer periods for chronic pain increase overdose risk
the ONA take:
According to a new study published in The Journal of Pain, researchers from the School of Medicine at the University of Texas have found that painkillers in higher doses and taken over longer periods for chronic pain increase the risk of overdose.
For the study, researchers developed a database to analyze medications, health care delivery, and comorbid conditions for over 200,000 HMO-enrolled patients who filled two or more prescriptions for opioids for non-cancer pain between 2009 and 2012. Results showed that a morphine equivalent total daily dose of 100mg or more significantly increased the risk of drug overdose.
In addition, patients who took 50-99mg/day were at an increased risk of drug overdose if they filled prescriptions totaling the morphine equivalent of at least 1,830mg over a 6-month period.
A second study published in The Journal of General Internal Medicine found that the risk of drug overdose is multiplicative if they are taking benzodiazepines on top of opioids.
The findings suggest that healthcare providers should be mindful of the drug combination that they are prescribing as well as how much opioids they have prescribed a patients over a period of time.
Painkillers in higher doses and taken over longer periods for chronic pain increase the risk of overdose.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|